특별한 당신을 위한
CELLTIUM develops curative therapeutics targeting Charcot-Marie-Tooth disease (CMT), diabetic peripheral neuropathies (DPN), amyotrophic lateral sclerosis (ALS), and other major neurological disorders.
News & Events
CELLTIUM is seeking for research talent as well as highly-motivated management. Let us know about your brilliant urge to make a real difference.